Alopecia Areata
📧 Sign up to get email alerts when something new happens for Alopecia Areata.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias [NA]
A terminated clinical trial from the University of Minnesota evaluated a mechanical intervention targeting the scalp microbiome for cicatric…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Psychosocial Stress on QOL in Saudi Arabian Patients With Alopecia Areata
This clinical trial update shows that the study on psychosocial stress and quality of life in Saudi Arabian patients with Alopecia Areata ha…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: To Compare the Efficacy of Weekly Azathioprine Pulse Versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia Areata [Phase 2]
A Phase 2 trial completed comparing weekly azathioprine pulse to betamethasone oral mini-pulse for moderate-to-severe alopecia areata to eva…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata [Phase 2]
A Phase 2 study evaluating DAXDILIMAB for moderate-to-severe Alopecia Areata has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata [Phase 2]
Phase 2 study evaluating the durability of response to CTP-543 in adults with moderate to severe Alopecia Areata; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age [Phase 1]
Phase 1 study evaluating ritlecitinib for severe alopecia areata in children aged 6 to under 12 has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: A Novel Formulation of Sildenafil-loaded Nanocarriers for Treatment of Alopecia Areata [EARLY_Phase 1]
A Phase 1 trial evaluated a sildenafil-loaded nanocarrier formulation for alopecia areata, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata [Phase 2]
Phase 2 trial evaluating oral etrasimod for adult moderate-to-severe alopecia areata has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata [Phase 3]
Phase 3 study of baricitinib in adults with severe or very severe alopecia areata completed; results posted.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA) [Phase 2]
A Phase 2 placebo-controlled trial evaluating STS01 for mild-to-moderate alopecia areata has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata [Phase 1, Phase 2]
Clinical trial update for topical jaktinib hydrochloride cream in alopecia areata in Phase 1/2; status unknown.
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi. [Phase 3]
A Phase 3 clinical trial evaluated the efficacy of oral tofacitinib for moderate to severe alopecia areata, including alopecia totalis and u…
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata [Phase 4]
Phase 4 trial update on needle-free delivery of intralesional triamcinolone for pediatric alopecia areata; study terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of farudodstat versus placebo in adults with alopecia areata.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Efficacy and Safety of LH-8 in Paediatric Alopecia Areata [Phase 2, Phase 3]
Phase 2/3 trial results report on the efficacy and safety of LH-8 for pediatric alopecia areata, completed.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata [NA]
Pilot study evaluating the safety and efficacy of apremilast in adults with moderate to severe Alopecia Areata has completed and posted resu…
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata [Phase 3]
Phase 3 clinical trial evaluating SHR0302 for efficacy and safety in adults with severe alopecia areata.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2) [Phase 3]
A phase 3 study evaluating the efficacy and safety of CTP-543 in adults with moderate to severe alopecia areata has completed and posted res…
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi. [Phase 4]
Phase 4 trial update evaluating the efficacy of oral apremilast for alopecia areata completed at a tertiary care hospital in Karachi.
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) [Phase 3]
Phase 3 trial THRIVE-AA1 evaluating CTP-543 for efficacy and safety in adults with moderate to severe alopecia areata has completed; results…
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata [Phase 2]
Phase 2 trial assessing two dosing regimens of CTP-543 for efficacy and tolerability in adults with alopecia areata; study completed with re…
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: Clinical Application of Stem Cell Educator Therapy in Alopecia Areata [Phase 2]
Phase 2 clinical trial update for Stem Cell Educator Therapy in alopecia areata, investigating alopecia areata, totalis, and universalis.
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA [Phase 2]
A Phase 2 placebo-controlled safety study of ritlecitinib (PF-06651600) in adults with alopecia areata was terminated, and the results have …
-
CLINICAL_TRIALS trial_result · 2022-12-09Clinical Trial Update: Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata [Phase 2]
A Phase 2 clinical trial evaluating two dose regimens of CTP-543 in adults with alopecia areata has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata [Phase 2]
Phase 2 trial evaluating the safety and efficacy of Jaktinib hydrochloride tablets for severe alopecia areata has completed.